These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 35956043)

  • 41. Urinary exosomal microRNA-145-5p and microRNA-27a-3p act as noninvasive diagnostic biomarkers for diabetic kidney disease.
    Han LL; Wang SH; Yao MY; Zhou H
    World J Diabetes; 2024 Jan; 15(1):92-104. PubMed ID: 38313849
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Circulating plasma microRNAs in the detection of esophageal squamous cell carcinoma.
    Zhang L; Dong B; Ren P; Ye H; Shi J; Qin J; Wang K; Wang P; Zhang J
    Oncol Lett; 2018 Sep; 16(3):3303-3318. PubMed ID: 30127929
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Circulating Exosomal miRNAs as Novel Biomarkers Perform Superior Diagnostic Efficiency Compared With Plasma miRNAs for Large-Artery Atherosclerosis Stroke.
    Niu M; Li H; Li X; Yan X; Ma A; Pan X; Zhu X
    Front Pharmacol; 2021; 12():791644. PubMed ID: 34899352
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of a serum-based miRNA signature for response of esophageal squamous cell carcinoma to neoadjuvant chemotherapy.
    Niwa Y; Yamada S; Sonohara F; Kurimoto K; Hayashi M; Tashiro M; Iwata N; Kanda M; Tanaka C; Kobayashi D; Nakayama G; Koike M; Fujiwara M; Kodera Y
    J Transl Med; 2019 Jan; 17(1):1. PubMed ID: 30602370
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Subpopulations of exosomes purified via different exosomal markers carry different microRNA contents.
    Wu SC; Kuo PJ; Rau CS; Wu YC; Wu CJ; Lu TH; Lin CW; Tsai CW; Hsieh CH
    Int J Med Sci; 2021; 18(4):1058-1066. PubMed ID: 33456364
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MiR-141-3p is upregulated in esophageal squamous cell carcinoma and targets pleckstrin homology domain leucine-rich repeat protein phosphatase-2, a negative regulator of the PI3K/AKT pathway.
    Ishibashi O; Akagi I; Ogawa Y; Inui T
    Biochem Biophys Res Commun; 2018 Jun; 501(2):507-513. PubMed ID: 29738771
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum Exosomal MicroRNAs as Potential Circulating Biomarkers for Endometriosis.
    Zhang L; Li H; Yuan M; Li D; Sun C; Wang G
    Dis Markers; 2020; 2020():2456340. PubMed ID: 32076458
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma.
    Tanaka Y; Kamohara H; Kinoshita K; Kurashige J; Ishimoto T; Iwatsuki M; Watanabe M; Baba H
    Cancer; 2013 Mar; 119(6):1159-67. PubMed ID: 23224754
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exosomal miR-301a-3p from esophageal squamous cell carcinoma cells promotes angiogenesis by inducing M2 polarization of macrophages via the PTEN/PI3K/AKT signaling pathway.
    Shou Y; Wang X; Chen C; Liang Y; Yang C; Xiao Q; Li H; Wang S; Shu J; Tian X; Chen K
    Cancer Cell Int; 2022 Apr; 22(1):153. PubMed ID: 35436935
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A serum exosomal microRNA panel as a potential biomarker test for gastric cancer.
    Wang N; Wang L; Yang Y; Gong L; Xiao B; Liu X
    Biochem Biophys Res Commun; 2017 Nov; 493(3):1322-1328. PubMed ID: 28986250
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
    Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
    Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of plasma exosomal miRNAs as potential diagnostic biomarkers of lymph node metastasis in papillary thyroid carcinoma.
    Chen W; Li G; Li Z; Zhu J; Wei T; Lei J
    Endocrine; 2022 Mar; 75(3):846-855. PubMed ID: 34854020
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic and prognostic implications of a serum miRNA panel in oesophageal squamous cell carcinoma.
    Wu C; Wang C; Guan X; Liu Y; Li D; Zhou X; Zhang Y; Chen X; Wang J; Zen K; Zhang CY; Zhang C
    PLoS One; 2014; 9(3):e92292. PubMed ID: 24651474
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multiplex Analysis of Cerebrospinal Fluid and Serum Exosomes MicroRNAs of Untreated Relapsing Remitting Multiple Sclerosis (RRMS) and Proposing Noninvasive Diagnostic Biomarkers.
    Mohammadinasr M; Montazersaheb S; Molavi O; Kahroba H; Talebi M; Ayromlou H; Hejazi MS
    Neuromolecular Med; 2023 Sep; 25(3):402-414. PubMed ID: 37020076
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Exosomal onco-miRs from serum of patients with adenocarcinoma of the esophagus: comparison of miRNA profiles of exosomes and matching tumor.
    Warnecke-Eberz U; Chon SH; Hölscher AH; Drebber U; Bollschweiler E
    Tumour Biol; 2015 Jun; 36(6):4643-53. PubMed ID: 25631748
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exosomal miRNA Signatures for Late-Onset Acute Graft-Versus-Host Disease in Allogenic Hematopoietic Stem Cell Transplantation.
    Yoshizawa S; Umezu T; Saitoh Y; Gotoh M; Akahane D; Kobayashi C; Ohyashiki JH; Ohyashiki K
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142940
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum-Derived Exosomal MicroRNA Profiles Can Predict Poor Survival Outcomes in Patients with Extranodal Natural Killer/T-Cell Lymphoma.
    Ryu KJ; Lee JY; Choi ME; Yoon SE; Cho J; Ko YH; Shim JH; Kim WS; Park C; Kim SJ
    Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33261029
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of serum exosomal miRNA biomarkers for diagnosis of Rheumatoid arthritis.
    Gong J; Zhang X; Khan A; Liang J; Xiong T; Yang P; Li Z
    Int Immunopharmacol; 2024 Mar; 129():111604. PubMed ID: 38320350
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exosomal miR-202 derived from leukorrhea as a potential biomarker for endometriosis.
    Zheng L; Sun DF; Tong Y
    J Int Med Res; 2023 Jan; 51(1):3000605221147183. PubMed ID: 36597409
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification and validation of hub microRNAs dysregulated in esophageal squamous cell carcinoma.
    Sang C; Chao C; Wang M; Zhang Y; Luo G; Zhang X
    Aging (Albany NY); 2020 May; 12(10):9807-9824. PubMed ID: 32412911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.